Featured Sequencing Technologies
Explore our premier high-throughput sequencing products designed to support complex transcriptome and genome analysis for industrial, clinical, and agricultural research.
The Rise of Full-Length mRNA-Seq in India's Biotech Landscape
India's biotechnology and pharmaceutical sectors are undergoing an unprecedented digital and molecular transformation. Driven by initiatives like the Genome India Project and a rapidly growing network of bioclusters in Bengaluru, Hyderabad, Pune, and New Delhi, the demand for advanced sequencing solutions has skyrocketed. Traditional short-read sequencing technologies, while useful, often fail to capture the full complexity of eukaryotic transcriptomes. This is where Full-Length mRNA Sequencing (mRNA-Seq) steps in as a game-changing solution.
By utilizing long-read sequencing platforms such as PacBio (Iso-Seq) and Oxford Nanopore, researchers can now sequence entire RNA molecules from end-to-end without fragmentation. This allows for the precise characterization of alternative splicing events, novel isoform identification, fusion genes, and allele-specific expression. In India, where genetic diversity in both human populations and native flora/fauna is exceptionally high, full-length transcriptomics is unlocking biological insights that were previously hidden in short-read data.
Furthermore, the Indian contract research organization (CRO) market has matured significantly. Biotech firms and academic institutes are no longer looking for basic raw data; they demand comprehensive, end-to-end multi-omics pipelines integrated with robust bioinformatics. This transition is fueling the adoption of full-length mRNA-seq in localized industrial applications, ranging from the development of biosimilars to precision oncology trials.
Localized Application Scenarios in the Indian Subcontinent
1. Agriculture & Climate Resilience
India's economy relies heavily on agriculture. Organizations like the Indian Council of Agricultural Research (ICAR) and international bodies like ICRISAT are leveraging full-length transcriptome sequencing to study crop responses to environmental stresses. By mapping full-length transcripts in staples like rice, wheat, and chickpea, researchers can pinpoint precise splice variants associated with drought, salinity, and pest resistance, accelerating molecular breeding programs.
2. Biopharma & Vaccine Development
Known as the "pharmacy of the world," India is a powerhouse in vaccine and biosimilar manufacturing. The development of mRNA vaccines and therapeutic monoclonal antibodies requires rigorous characterization of expression profiles. Full-length mRNA-Seq ensures that recombinant cell lines express the exact sequence of interest without unwanted splice variations or mutations, ensuring product safety and efficacy.
3. Clinical Research & Oncology
In Indian oncology centers, understanding the genetic heterogeneity of cancers within the local population is critical. Full-length mRNA-Seq allows clinical researchers to identify novel fusion transcripts and aberrant splicing patterns specific to Indian patients, paving the way for personalized therapeutic targets and diagnostic biomarkers.
Biomarker Technologies (BMKGene): Leading Global Genomics
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Our Cutting-Edge Sequencing Platforms
Long-Read & Single-Cell
- PacBio Platforms: Sequel II, Sequel, RSII
- Nanopore Platforms: PromethION P48, GridION X5, MinION
- 10X Genomics: 10X ChromiumX, 10X Chromium Controller
High-Throughput Short-Read
- Illumina Platforms: NovaSeq
- BGI-Sequencing: DNBSEQ-G400, DNBSEQ-T7
- Mass Spectrometry & Imaging: Bionano Irys system, Waters XEVO G2-XS QTOF, QTRAP 6500+
Bioinformatics Cloud
- Self-Developed BMKCloud: Reliable, easy-to-use online bioinformatics platform
- Processing Power: CPUs with 41,104 memory, 3 PB total storage
- Performance: 4,260 computing cores with peak computing power over 121,708.8 Gflop per second
Fully Automated Platform for Next-Generation Sequencing
Brilliant Lab 1000 (BL1000)
Biomarker Technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
By automating sample preparation, liquid handling, and library construction, BMKGENE greatly improves the entire line of sequencing products in terms of throughput, consistency, delivery quality, and turnaround time. This state-of-the-art facility minimizes human error, providing Indian researchers and global clients with highly reproducible sequencing services.
Enterprise Qualifications & Global Certifications
Our commitment to quality is backed by international standards and proprietary patents. We maintain strict quality control protocols across all molecular laboratories.
The Future of Transcriptomics in the Indian Genomics Market
The Indian genomics market is projected to grow at a compound annual growth rate (CAGR) of over 15% in the coming years. This growth is driven by several key factors. First, the cost of long-read sequencing has decreased significantly, making full-length mRNA-Seq accessible to medium-sized laboratories and universities. Second, the integration of artificial intelligence (AI) and machine learning (ML) with transcriptome data is accelerating drug discovery. By feeding full-length isoform datasets into AI models, pharmacologists can predict how different splicing isoforms will interact with small molecule drugs.
Furthermore, there is a growing push towards localized research. The Indian genetic footprint is distinct from Western cohorts, meaning that reference databases built on Caucasian populations are often inadequate for Indian clinical trials. Generating localized reference transcriptomes is crucial. BMKGene is committed to supporting Indian researchers by providing high-quality, high-throughput sequencing services coupled with our BMKCloud bioinformatics platform, ensuring that data generated is translated into actionable biological discoveries.
Our Complete Product Portfolio
Discover our full range of molecular biological services, from high-throughput metagenomics to advanced de novo genome assemblies.
